{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:00:30Z","timestamp":1761490830292,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Romanian Ministry for Research and Innovations","award":["PN 19-41 01 03\/34N\/2009; Aditional act 2\/2019"],"award-info":[{"award-number":["PN 19-41 01 03\/34N\/2009; Aditional act 2\/2019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>New 1\u2032-homocarbanucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane skeleton as sugar moiety were synthesized. The pyrimidine analogs with uracil, 5-fluorouracil, thymine and cytosine and key intermediate with 6-chloropurine (5) as nucleobases were synthesized by a selective Mitsunobu reaction on the primary hydroxymethyl group in the presence of 5-endo-hydroxyl group. Adenine and 6-substituted adenine homonucleosides were obtained by the substitution of the 6-chlorine atom of the key intermediate 5 with ammonia and selected amines, and 6-methoxy- and 6-ethoxy substituted purine homonucleosides by reaction with the corresponding alkoxides. No derivatives appeared active against entero, yellow fever, chikungunya, and adeno type 1viruses. Two compounds (6j and 6d) had lower IC50 (15 \u00b1 2 and 21 \u00b1 4 \u00b5M) and compound 6f had an identical value of IC50 (28 \u00b1 4 \u00b5M) to that of acyclovir, suggesting that the bicyclo[2.2.1]heptane skeleton could be further studied to find a candidate for sugar moiety of the nucleosides.<\/jats:p>","DOI":"10.3390\/molecules24132446","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T11:14:49Z","timestamp":1562152489000},"page":"2446","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["New HSV-1 Anti-Viral 1\u2032-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3867-1064","authenticated-orcid":false,"given":"Constantin I.","family":"T\u0103nase","sequence":"first","affiliation":[{"name":"National Institute for Chemical-Pharmaceutical Research and Development, Department of Bioactive Substances and Pharmaceutical Technologies, 112 Vitan Av., 031299 Bucharest-3, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Dr\u0103ghici","sequence":"additional","affiliation":[{"name":"Organic Chemistry Center \u201cC.D.Nenitescu\u201d, Spectroscopy Laboratory, 202 B Splaiul Independentei, 060023 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-752X","authenticated-orcid":false,"given":"Anamaria","family":"Hanganu","sequence":"additional","affiliation":[{"name":"Organic Chemistry Center \u201cC.D.Nenitescu\u201d, Spectroscopy Laboratory, 202 B Splaiul Independentei, 060023 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-7653","authenticated-orcid":false,"given":"Lucia","family":"Pintilie","sequence":"additional","affiliation":[{"name":"National Institute for Chemical-Pharmaceutical Research and Development, Department of Bioactive Substances and Pharmaceutical Technologies, 112 Vitan Av., 031299 Bucharest-3, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Maganu","sequence":"additional","affiliation":[{"name":"Organic Chemistry Center \u201cC.D.Nenitescu\u201d, Spectroscopy Laboratory, 202 B Splaiul Independentei, 060023 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandrina","family":"Volobueva","sequence":"additional","affiliation":[{"name":"Department of Virology, Pasteur Institute of Epidemiology and Microbiology, 197101 St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Sinegubova","sequence":"additional","affiliation":[{"name":"Department of Virology, Pasteur Institute of Epidemiology and Microbiology, 197101 St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5224-3771","authenticated-orcid":false,"given":"Vladimir V.","family":"Zarubaev","sequence":"additional","affiliation":[{"name":"Department of Virology, Pasteur Institute of Epidemiology and Microbiology, 197101 St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Micobiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Herestraat 49, BE-3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Micobiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Herestraat 49, BE-3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Slita","sequence":"additional","affiliation":[{"name":"KU Leuven Department of Micobiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Herestraat 49, BE-3000 Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2174\/092986708784221449","article-title":"Cytotoxic nucleoside analogues: Different strategies to improve their clinical efficacy","volume":"15","author":"Galmarini","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.4161\/cc.3.8.1023","article-title":"Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy","volume":"3","author":"Blagosklonny","year":"2004","journal-title":"Cell Cycle"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1021\/acs.chemrev.6b00209","article-title":"Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs","volume":"116","author":"Shelton","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/jm900932g","article-title":"Highlights in the discovery of antiviral drugs: A personal retrospective","volume":"53","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00003495-200969020-00002","article-title":"Antimicrobial strategies: Inhibition of viral polymerases by 3\u2032-hydroxyl nucleosides","volume":"69","author":"Deval","year":"2009","journal-title":"Drugs"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","year":"2004","journal-title":"J. Clin. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","article-title":"The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold","volume":"154","author":"Yates","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejmech.2016.04.034","article-title":"1\u2032-homonucleosides and their structural analogues: A Review","volume":"118","author":"Wroblewski","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1016\/j.bmc.2010.04.023","article-title":"Bacterial transferase MraY inhibitors: Synthesis and biological evaluation","volume":"18","author":"Clouet","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.5012\/bkcs.2011.32.3.961","article-title":"Synthesis and Binding Affinity of Homologated Adenosine Analogues as A3 Adenosine Receptor Ligands","volume":"32","author":"Lee","year":"2011","journal-title":"Bull. Korean Chem. Soc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/bi061515r","article-title":"Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues","volume":"46","author":"Wing","year":"2007","journal-title":"Biochemistry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1016\/j.bmc.2010.08.018","article-title":"Design, synthesis, and binding of homologated truncated 4\u2032-thioadenosine derivatives at the human A3 adenosine receptors","volume":"18","author":"Lee","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/jm9705869","article-title":"Synthesis and Antiviral Activity of Novel Acyclic Nucleosides: Discovery of a Cyclopropyl Nucleoside with Potent Inhibitory Activity against Herpesviruses","volume":"41","author":"Sekiyama","year":"1998","journal-title":"J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/jm9904194","article-title":"Synthesis and Antiviral Activity of Novel Anti-VZV 5-Substituted Uracil Nucleosides with a Cyclopropane Sugar Moiety","volume":"43","author":"Onishi","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/jm9705723","article-title":"(Z)- and (E)-2-((hydroxymethyl)cyclo-propylidene)methyladenine and -guanine. New nucleoside analogues with a broad- spectrum antiviral activity","volume":"41","author":"Qiu","year":"1998","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-3542(02)00129-8","article-title":"Z-isomers of 2-hy-droxymethylcyclopropylidenemethyl adenine (synadenol) and guanine (synguanol) are active against ganciclovir- and foscarnet-resistant human cytomegalovirus UL97 mutants","volume":"56","author":"Baldanti","year":"2002","journal-title":"Antivir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1016\/j.tet.2005.04.023","article-title":"Synthesis of new nucleoside analogues comprising a methylenecyclobutane unit","volume":"61","author":"Danappe","year":"2005","journal-title":"Tetrahedron"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/15257779908041557","article-title":"Synthesis and Biological Evaluation of 1,2-Disubstituted Carbonucleosides of 6-Substituted Purine and 8-Azapurine","volume":"18","author":"Santana","year":"1999","journal-title":"Nucl. Nucl."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1080\/07328319608002434","article-title":"Synthesis and Antiviral Activities of Some Novel Carbocyclic Nucleosides","volume":"15","author":"Balo","year":"1996","journal-title":"Nucl. Nucl."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/S0040-4020(98)83020-2","article-title":"Synthesis of novel carbocyclic nucleosides with a cyclopentenyl ring: Homocarbovir and analogues","volume":"54","author":"Balo","year":"1998","journal-title":"Tetrahedron"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0040-4020(02)01195-X","article-title":"A flexible synthesis of carbanucleosides and 5\u2032-nor-1\u2032-homo carbanucleosides from a common precursor","volume":"58","author":"Rajapan","year":"2002","journal-title":"Tetrahedron"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ardp.200500987","article-title":"Synthesis and Anti-HCMV Activity of Novel 5\u2032-Norcarboacyclic Nucleosides","volume":"338","author":"Kim","year":"2005","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1002\/1099-0690(200111)2001:21<4061::AID-EJOC4061>3.0.CO;2-3","article-title":"Chiral Synthons from the Iridoid Glucoside Antirrhinoside\u2212Synthesis of a Carbocyclic Homonucleoside Analogue","volume":"21","author":"Bianco","year":"2001","journal-title":"Eur. J. Org. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1002\/(SICI)1099-0690(199812)1998:12<2931::AID-EJOC2931>3.0.CO;2-C","article-title":"Synthesis of Carbocyclic Homo-N-Nucleosides from Iridoids","volume":"12","author":"Franzyk","year":"1998","journal-title":"Eur. J. Org. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/07328319708002530","article-title":"Synthesis and Antiviral and Cytostatic Activities of Carbocyclic Nucleosides Incorporating a Modified Cyclopentane Ring. I: Guanosine Analogues","volume":"16","author":"Blanco","year":"1997","journal-title":"Nucl. Nucl."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1080\/07328319808004237","article-title":"Synthesis, Antiviral and Cytostatic Activities of Carbocyclic Nucleosides Incorporating a Modified Cyclopentane Ring. Part 2:1 Adenosine and Uridine Analogues","volume":"17","author":"Nieto","year":"1998","journal-title":"Nucl. Nucl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1081\/NCN-120003289","article-title":"Synthesis, Antiviral and Cytostatic Activities, of Carbocyclic Nucleosides Incorporating a Modified Cyclopentane Ring. IV. Adenosine and Uridine Analogues","volume":"21","author":"Nieto","year":"2002","journal-title":"Nucl. Nucl. Nucleic Acids"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1055\/s-2002-31956","article-title":"Synthesis and Cytostatic Activities of New 6-Substituted Purinylcarbonucleosides Derived from Indan","volume":"21","author":"Fernandez","year":"2002","journal-title":"Synthesis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1016\/j.bmc.2003.09.005","article-title":"Synthesis and QSAR study of the anticancer activity of some novel indane carbocyclic nucleosides","volume":"11","author":"Yao","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Garcia, M.D., Caamano, O., Fernandez, F., Lopez, M.C., and De Clerck, E. (2005). Synthesis of Purinyl homo-Carbonucleoside Derivatives of 2-Benzylcyclopenta[c]pyrazol. Synthesis, 925\u2013932.","DOI":"10.1055\/s-2005-861831"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Garcia, M.D., Caamano, O., Fernandez, F., Abeijon, P., and Blanco, J.M. (2006). Synthesis of New 1\u2032(N)-Homocarbanucleosides Based on 1-Methylcyclopenta[c]pyrazole Scaffold. Synthesis, 73\u201380.","DOI":"10.1055\/s-2005-918451"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Garcia, M.D., Caamano, O., Fernandez, F., Garcia-Mera, X., and Perez-Castro, I. (2006). Synthesis of Purinyl and Pyrimidinyl 1\u2032(N)-Homocarbanucleosides Based on a 1-Methylcyclopenta[c]pyrazole Scaffold; Part 2. Synthesis, 3967\u20133972.","DOI":"10.1055\/s-2006-950316"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bmc.2013.10.056","article-title":"New carbocyclic nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; synthesis, X-ray crystallography and anticancer activity","volume":"22","author":"Shova","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1016\/j.bmc.2015.08.033","article-title":"New carbocyclic N6-substituted adenine and pyrimidine nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; synthesis, antiviral, anticancer activity and X-ray crystallography","volume":"23","author":"Cojocaru","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_35","first-page":"147","article-title":"New Bicyclo[2.2.1]heptane Nucleoside Analogues as Antitumor Agents","volume":"60","author":"Cocu","year":"2009","journal-title":"Rev. Chim. (Bucharest)"},{"key":"ref_36","unstructured":"T\u0103nase, C., Cojocaru, A., and Dr\u0103ghici, C. (2015). New 1\u2032-homocarbonucleosides analogs with a constrained bicyclo[2.2.1]heptane fragment. (RO 141479 A2), Patent."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.37358\/RC.18.9.6551","article-title":"New constrained Amines in a Bicyclo[2.2.1]heptane Skeleton","volume":"69","author":"Pintilie","year":"2018","journal-title":"Rev. Chim. (Bucharest)"},{"key":"ref_38","unstructured":"T\u0103nase, C., Dr\u0103ghici, C., Negu\u021b, C., and Pintilie, L. (2019). Bicyclo[2.2.1]heptane Amines Protected at the Hydroxyl Group. (RO 133248 A2), Patent."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-5793(98)01619-6","article-title":"Structure to 1.9 \u00c5 resolution of a complex with herpex simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of acyclovir","volume":"443","author":"Bennett","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.3390\/molecules20035099","article-title":"Docking and antiherpetic activity of 2-aminobenzo[de]-isoquinoline-1,3-diones","volume":"20","author":"Alswaidan","year":"2015","journal-title":"Molecule"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Delivery Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","article-title":"Empirical scoring functions for advanced protein-ligand docking with plants","volume":"49","author":"Korb","year":"2009","journal-title":"J. Chem. Inf. Model"},{"key":"ref_43","first-page":"380","article-title":"Secondary Compounds and Intermediates in Deprotection of the Benzoate Groups of O2,O4- and N1,O4-Nucleoside Analogues With Optically Active Bicyclo[2.2.1]Heptane Sugar Moieties","volume":"62","author":"Enache","year":"2011","journal-title":"Rev. Chim. (Bucharest)"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejmech.2018.03.038","article-title":"Synthesis of 3\u2032-halo-5\u2032-norcarbocyclic nucleoside phosphonates as potential anti-HIV agents","volume":"150","author":"Hamon","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-981-10-7230-7_6","article-title":"Antiviral Drugs Against Alphaherpesvirus","volume":"1045","author":"Shiraki","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/jac\/dku200","article-title":"A novel benzonitrile analogue inhibits rhinovirus replication","volume":"69","author":"Lacroix","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejmech.2014.09.062","article-title":"Syntesis and evaluation of imidazole-4,5- and pyrazine-2,3-dicarboxamides targeting dengue and yellow fever virus","volume":"87","author":"Saudi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"31819","DOI":"10.1038\/srep31819","article-title":"The viral capping enzyme nsP1: A novel target for the inhibition of chikungunya virus infection","volume":"6","author":"Delang","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/13\/2446\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:02:20Z","timestamp":1760187740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/24\/13\/2446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":48,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["molecules24132446"],"URL":"https:\/\/doi.org\/10.3390\/molecules24132446","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2019,7,3]]}}}